Innovating Bi-specific T Cell Engagers with Nona Biosciences’ HBICE Platform

Time: 4:30 pm
day: Day One

Details:

  • HCAb Harbour Mice® is the world’s leading fully human heavy chain only transgenic mice platform, producing highly developable fully human VH, offering versatile building blocks for bispecific antibody development
  • Nona’s CD3-targeting HBICE® (HCAb-based Bispecific Immune Cell Engager) is a plug-and-play platform for rapidly developing CD3 bispecific antibodies for both oncology and immunology indications

Speakers: